InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by WHEELER CRAIG A, Director. Officer active across 3 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 5 disclosures have been published. The latest transaction was filed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
24,444 shares
Common Stock
SEC:0001193125-26-224585·
24,444 shares
Common Stock
SEC:0001193125-26-224585:0·
012,671 shares0
Common Stock
SEC:0001209191-22-035857:0·
010,115 shares0
Common Stock
SEC:0001209191-21-040379·
010,115 shares0
Common Stock
SEC:0001209191-21-040379:0·
5 of 5 declarations
About WHEELER CRAIG A
Craig A. Wheeler is a Director at Apellis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc. He brings expertise in management and business strategy to the boards. His role is essential in guiding strategic decisions and ensuring the sustainable growth of the companies.
